[Action of framycetin alone or with chloromycetin on gastrointestinal inflammation caused by Escherichia coli 111 B4, 55 B5, and 26 B6].
D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D000904:Antibiotics, Antitubercular; D001432:Bacteriology; D002701:Chloramphenicol / Q000627:therapeutic use*; D004926:Escherichia coli; D004927:Escherichia coli Infections; D005601:Framycetin; D005759:Gastroenteritis / Q000209:etiology*; D006801:Humans; D007223:Infant; D007228:Infant Nutrition Disorders / Q000382:microbiology*; D007249:Inflammation
D000900:Anti-Bacterial Agents; D000904:Antibiotics, Antitubercular; D005601:Framycetin; D002701:Chloramphenicol
ANTIBIOTICS/therapeutic use; CHLORAMPHENICOL/therapeutic use; ESCHERICHIA COLI/infections; GASTROENTERITIS/etiology and pathogenesis; INFANT NUTRITION DISORDERS/bacteriology
Action de la framycétine seule ou associée à la chloromycétine sur les gastro-entéro-colites à Escherichia coli 111 B4-55 B5-26 B6.